The DOJ Suggests Medical Marijuana 280E Changes Should Apply Retroactively. For Now, The Treasury Says Otherwise.

The U.S. Department of the Treasury and the Internal Revenue Service are preparing to issue new tax guidance following the Department of Justice’s final order to reclassify certain medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act. This shift, driven by President Donald Trump’s December 2025 executive order, is poised to deliver significant tax relief to state-licensed medical marijuana businesses by lifting the punitive constraints of Section 280E.

Section 280E of the Internal Revenue Code has long barred businesses dealing in Schedule I or II substances from claiming standard deductions and credits, forcing cannabis operators to shoulder higher effective tax rates by disallowing write-offs for expenses like payroll and rent. With the DOJ’s action placing FDA-approved marijuana products and state-licensed medical marijuana into Schedule III, qualifying businesses are expected to escape these restrictions, potentially transforming their financial outlook.

Treasury officials noted that the rescheduling will generally apply to the full taxable year including the effective date of the DOJ’s final order for activities no longer tied to Schedule I or II substances. This transition rule aims to provide immediate clarity for medical marijuana operators planning their 2026 filings.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

READ: US Plans Retroactive 280E Tax Break For Operators Per Marijuana Reclassification, But Not For All

However, a notable distinction has emerged regarding the scope of relief. The DOJ administrator has urged the Treasury to consider retrospective relief from Section 280E liability for prior taxable years in which state licensees operated under medical marijuana licenses, a move that could allow qualifying operators to reclaim past overpayments or amend returns.

Here’s the text included within today’s Department of Justice Final Order:

“The Administrator encourages the Secretary of the Treasury to consider providing retrospective relief from Section 280E liability for taxable years in which a state licensee operated under a state medical marijuana license.”

And here’s the text within the Department of the Treasury’s press release:

“Guidance is also expected to include a transition rule providing that, for purposes of section 280E, rescheduling generally will be considered to first apply for a business’s full taxable year that includes the effective date of the Final Order, for the business’s activities that do not involve Schedule I or II controlled substances as a result of the Final Order.”

The Treasury has yet to confirm whether it will adopt the recommendation from the DOJ, or instead proceed with changes just applying to the current taxable year, creating uncertainty over the full extent of potential benefits.

PTX Metals Inc. — sponsored Sponsored · PTX Metals Inc.

The guidance will also tackle complexities for businesses with mixed operations. Companies juggling Schedule III medical marijuana activities alongside Schedule I or II substances—such as unlicensed crops or bulk marijuana—can expect rules on expense apportionment to clarify how deductions apply across their revenue streams.

READ: US Justice Department Reclassifies Marijuana to Schedule III in Historic Drug Policy Shift

A critical limitation shapes the impact of this policy shift. The tax relief targets only medical marijuana operators, leaving the broader adult-use cannabis sector under the existing federal constraints of Section 280E. For multi-state operators, the split between medical and recreational revenue could now dictate their tax burden more than ever.

The divide underscores a fragmented landscape for the cannabis industry in 2026. While medical operators may gain a competitive edge with lower tax pressures, adult-use businesses remain sidelined, facing effective tax rates that can exceed 70% in some cases due to disallowed deductions.


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Trump Signs Order to Move Cannabis to Schedule III

President Donald Trump signed an executive order Thursday to push marijuana from Schedule I toward...

Friday, December 19, 2025, 03:02:00 PM

Congressional Staffers Predict Marijuana Rescheduling This Year Despite Process Delays

Congressional staffers from both parties say they expect federal marijuana rescheduling to be completed by...

Tuesday, August 19, 2025, 02:21:00 PM

Cannabis to Be Reclassified Under Trump as Early as Wednesday

The Trump administration is poised to reclassify marijuana under federal law as early as Wednesday...

Wednesday, April 22, 2026, 12:35:33 PM

Donald Trump Is Pro Pot? Executive Order Rumoured For Marijuana Rescheduling

President Donald Trump is preparing an executive order that would direct federal agencies to pursue...

Friday, December 12, 2025, 11:15:00 AM

DEA Nominee Views Cannabis Reclassification as Priority, Stops Short of Guarantee

Terrance Cole, tapped by President Trump to lead the Drug Enforcement Administration, testified his administration...

Thursday, May 1, 2025, 02:11:00 PM